1-6 of 6
Grzegorz Helbig, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HLA Class I-Specific Effects in AML with Mutated Nucleophosmin

Kateřina Kuželová, PhD, Christoph Röllig, MD, Zdenek Racil, MD, Juliane S. Stickel, MD, Barbora Brodská, PhD, Johannes Schetelig, MD MSc, Christian Thiede, MD, Gerhard Ehninger, MD, Grzegorz Helbig, MD PhD, Slawomira Kyrcz-Krzemien, Prof, Jiri Mayer, Petr Cetkovsky, MD MBA, PhD
Journal: Blood
Blood (2016) 128 (22): 5230.
https://doi.org/10.1182/blood.V128.22.5230.5230
Published: 2016
Journal Articles

Cladribine, Cytarabine and Mitoxantrone As Treatment Intensification for Patients with Acute Myeloid Leukemia with the Excess of Bone Marrow Blasts on Day 14 of the First Induction. Prospective, Multicenter Study By the Polish Adult Leukemia Group (PALG)

Agnieszka Pluta, MD PhD, Kamil Brzozowski, MD, Konrad Stepka, MD, Ewa Wawrzyniak, PhD, Anna Krawczynska, PhD, Anna Szmigielska-Kaplon, MD PhD, Olga Grzybowska-Izydorczyk, Magdalena Czemerska, MD PhD, Tomasz Gromek, MD PhD, Marek Hus, MD PhD, Grzegorz Helbig, MD PhD, Ewa Bodzenta, MD PhD, Sebastian Grosicki, MD PhD, Malgorzata Razny, MD PhD, Lukasz Bolkun, MD PhD, Janusz Kloczko, MD PhD, Wanda Knopinska-Posluszny, MD PhD, Agnieszka Piekarska, MD PhD, Andrzej Hellmann, MD PhD, Marta Sobas, MD PhD, Tomasz Wrobel, MD PhD, Elzbieta Patkowska, Ewa Lech-Maranda, MD PhD, Krzysztof Warzocha, Jerzy Holowiecki, MD PhD, Sebastian Giebel, Tadeusz Robak, MD PhD, Agnieszka Wierzbowska, MD PhD
Journal: Blood
Blood (2016) 128 (22): 213.
https://doi.org/10.1182/blood.V128.22.213.213
Published: 2016
Journal Articles

Immune Response in Acute Myeloid Leukemia with Mutated Nucleophosmin

Katerina Kuzelova, PhD, Barbora Brodská, PhD, Jana Marková, Grzegorz Helbig, MD PhD, Slawomira Kyrcz-Krzemien, MD PhD, Petr Cetkovsky, MD MBA, PhD
Journal: Blood
Blood (2015) 126 (23): 2572.
https://doi.org/10.1182/blood.V126.23.2572.2572
Published: 2015
Journal Articles

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Miroslaw Markiewicz, MD PhD, Monika Dzierzak-Mietla, MD PhD, Patrycja Zielinska, MD PhD, Agata Wieczorkiewicz-Kabut, MD PhD, Sylwia Mizia, MSci, Mariusz Matyja, MD, Krzysztof Bialas, MD, Grzegorz Helbig, MD PhD Prof., Anna Koclega, MD PhD, Malwina Rybicka, MD, Lech Sedlak, Tomasz Oleksy, Slawomira Kyrcz-Krzemien, MD PhD Prof.
Journal: Blood
Blood (2014) 124 (21): 5934.
https://doi.org/10.1182/blood.V124.21.5934.5934
Published: 2014
Journal Articles

Purine Analogues Based Induction Regimen Followed By Allo-HSCT Is An Effective Treatment Modality Of Philadelphia Chromosome-Positive Acute Myeloid Leukemia-Retrospective Analysis Of Polish Adult Leukemia Group (PALG)

Agnieszka Wierzbowska, MD, PhD, Anna Szmigielska-Kaplon, MD, PhD, Agnieszka Pluta, MD, PhD, Ewa Wawrzyniak, PhD, Sebastian Grosicki, MD, Grzegorz Helbig, MD, PhD, Wanda Knopinska-Posluszny, MD, PhD, Tomasz Gromek, MD, PhD, Ilona Seferynska, MD, PhD, Ewa Lech-Maranda, Jerzy Holowiecki, Tadeusz Robak
Journal: Blood
Blood (2013) 122 (21): 1461.
https://doi.org/10.1182/blood.V122.21.1461.1461
Published: 2013
Journal Articles

Occurrence and Treatment of Isolated Extramedullary Relapses after Allogeneic Hematopoietic Stem Cell Transplantation for Leukaemias: A Single Institute Experience with 442 Patients.

Dariusz Kata, MD, Jerzy Holowiecki, Jerzy Wojnar, MD, Beata Stella-Holowiecka, MD, Slawomira Krzemien, Krzysztof Wozniczka, MD, Grzegorz Helbig, MD
Journal: Blood
Blood (2006) 108 (11): 5337.
https://doi.org/10.1182/blood.V108.11.5337.5337
Published: 2006